Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain wave watch: new monitor may cut ICU delirium and ventilator time

NCT ID NCT06019078

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 21, 2026 · Updated 1 time

Summary

This study looked at whether adding a brain wave monitor (pEEG) to standard sedation checks helps reduce delirium and time on a breathing machine in ICU patients. Researchers followed 150 adults on ventilators who needed sedation. They compared those who got both the brain monitor and usual care to those who got usual care alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

150 people

The number who actually took part.

Started

Jan 2024

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult medical and surgical ICU patients .

Ages

17 to 110 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Admitted to ICU 2. Receive mechanical ventilator support during ICU stay 3. Require IV sedation or analgesic for a RASS -3 to -5 while ventilated 4. Discharged home from the hospital 5. Use of pEEG for sedation or analgesic titration 6. Able to read and speak English 7. Mechanically ventilated greater than 48 hours 8. Aged 17 years +1 day or greater 9. Consent to participate 10. Participants need a computer with a keyboard, internet access, and email access for the questionnaires and assessment and be able to use computer and internet. Exclusion Criteria: 1. Deceased during hospitalization 2. Intubated at a hospital not using SedLine \> 12 hours 3. Discharge to rehabilitation facility, long term care, or other outpatient setting 4. Inability to provide informed consent 5. Currently enrolled in any other research study involving drugs or devices 6. Is unable to be screened for delirium during ICU admission.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Analgesia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

agnosia Critical Illness delirium pain agnosia postintensive care syndrome substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Abbotsford Regional Hospital

    Abbotsford British Columbia, British Columbia, V2S0C2, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.